The Human Genome Project has made it possible to study biology and disease at the genetic and molecular level using high-throughput technologies. The NIH Chemical Genomics Center (NCGC) collaborates with researchers throughout the world to discover small molecule chemical probes of novel genes, pathways, and cellular phenotypes relevant to health and disease. The NCGC, together with the extramural centers of the Molecular Libraries Screening Center Network, is exploring the enormous number of proteins (numbering well over 100,000) encoded by the human and other genomes for which no small molecule chemical probes have been identified. In so doing, this initiative promises to significantly improve the understanding of mechanisms by which genes and their protein products function and accelerate the development of therapies for human diseases based on knowledge of the genome. This year has seen a dramatic increase in the NCGC's capacities, increasing staff from 19 to 30, and moving operations from start-up into production. The NCGC currently has over 20 active collaborations with researchers in the intramural, extramural, and pharma/biotech sectors. In this reporting period, the NCGC performed 28 screens comprising over 10 million miniaturized assays, and desposited over 7 million data fields to the public PubChem database. During this year, the NCGC developed a new screening paradigm, called Quantitative High Throughput Screening (qHTS), that generates dramatically better screening data than conventional HTS; this was published in the Proceedings of the National Academy of Sciences in August 2006.

Agency
National Institute of Health (NIH)
Institute
National Human Genome Research Institute (NHGRI)
Type
Intramural Research (Z01)
Project #
1Z01HG200319-03
Application #
7316058
Study Section
(GTB)
Project Start
Project End
Budget Start
Budget End
Support Year
3
Fiscal Year
2006
Total Cost
Indirect Cost
Name
Human Genome Research
Department
Type
DUNS #
City
State
Country
United States
Zip Code
Capuzzi, Stephen J; Sun, Wei; Muratov, Eugene N et al. (2018) Computer-Aided Discovery and Characterization of Novel Ebola Virus Inhibitors. J Med Chem 61:3582-3594
Nilubol, Naris; Boufraqech, Myriem; Zhang, Lisa et al. (2018) Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response. Oncotarget 9:33030-33042
Slavov, Svetoslav; Stoyanova-Slavova, Iva; Li, Shuaizhang et al. (2017) Why are most phospholipidosis inducers also hERG blockers? Arch Toxicol :
Li, Hao; Sun, Wei; Huang, Xiuli et al. (2017) Efficient Synthesis of 1,9-Substituted Benzo[h][1,6]naphthyridin-2(1H)-ones and Evaluation of their Plasmodium falciparum Gametocytocidal Activities. ACS Comb Sci 19:748-754
Lal-Nag, Madhu; McGee, Lauren; Guha, Rajarshi et al. (2017) A High-Throughput Screening Model of the Tumor Microenvironment for Ovarian Cancer Cell Growth. SLAS Discov 22:494-506
Torimoto-Katori, Nao; Huang, Ruili; Kato, Harutoshi et al. (2017) In Silico Prediction of hPXR Activators Using Structure-Based Pharmacophore Modeling. J Pharm Sci 106:1752-1759
Wu, Leihong; Liu, Zhichao; Auerbach, Scott et al. (2017) Integrating Drug's Mode of Action into Quantitative Structure-Activity Relationships for Improved Prediction of Drug-Induced Liver Injury. J Chem Inf Model 57:1000-1006
Sun, Hongmao; Huang, Ruili; Xia, Menghang et al. (2017) Prediction of hERG Liability - Using SVM Classification, Bootstrapping and Jackknifing. Mol Inform 36:
Fuller, John A; Berlinicke, Cynthia A; Inglese, James et al. (2016) Use of a Machine Learning-Based High Content Analysis Approach to Identify Photoreceptor Neurite Promoting Molecules. Adv Exp Med Biol 854:597-603
Sakamuru, Srilatha; Attene-Ramos, Matias S; Xia, Menghang (2016) Mitochondrial Membrane Potential Assay. Methods Mol Biol 1473:17-22

Showing the most recent 10 out of 76 publications